Although most Ewing sarcomas are recognised morphologically and by immunohistochemical identification of the surface glycoprotein CD99, molecular genetic confirmation of the Ewing sarcoma translocation is mandated. The gene discussed is CD99; the disease is Ewing sarcoma.